Table 1.
Conventional DC subset | Phenotype | Phenotype | Proposed function | Proposed function |
---|---|---|---|---|
Human | Mouse | TDLN | Tumor | |
cDC1 | CD11c+, HLA-DR+, CD141+, CLEC9a+ | CD11c+, MHC-II+, XCR1+, CD8a+, CD103+/− | Priming/primary activation of CD8 T cells Cross-presentation |
Migration from tumor to deliver tumor antigens to TDLN Associated with tumor control and better patient survival |
cDC2 | CD11c+, HLA-DR+, CD1c+, CLEC10a+ pro-inflammatory subset: CD14+ CD163+ |
CD11c+, MHC-II+, CD11b+, CD16− | Priming/activation of CD4 T cells | Most abundant population within tumors Lineage differentiation of CD4 T cells via diverse cytokine secretion Support stem-like CD8 T cells within lymphoid-like niches in the tumor Pro-inflammatory cytokine secretion from CD14+ CD163+ cDC2s |
The function and primary location of each of these DCs are expanded upon in the main text.